Physician

Reema Syed, MD

According to 2025 Medicare claims, Reema Syed, MD (NPI: 1578806972) practices ophthalmology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is RETINAL DIAGNOSTIC CENTER A MEDICAL CORPORATION (NPI: 1518030568; TIN: 942711267) and primary practice location at 95076-2491. Syed is affiliated with the Lore Health ACO (ACO ID: A5192), participating under the MSSP model.

Syed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 741 traditional Medicare patients, billed 24,405 HCPCS/CPT codes, and received $1,038,558 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 314 prescription claims across 117 beneficiaries totaling $16,839 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 22 records totaling $950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $500 to $16,839. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$519K$1.0M2019 Medicare payment: $1,709 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,823 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $10,755 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,038,558 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191317$1,709
2020N/RN/RN/R
20211338$2,823
2022N/RN/RN/R
20231791$10,755
202474124,405$1,038,558

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$62K2015 Drug cost: $500 (USD; Tot_Drug_Cst)2016 Drug cost: $1,362 (USD; Tot_Drug_Cst)2017 Drug cost: $1,448 (USD; Tot_Drug_Cst)2018 Drug cost: $18,365 (USD; Tot_Drug_Cst)2019 Drug cost: $7,514 (USD; Tot_Drug_Cst)2020 Drug cost: $15,248 (USD; Tot_Drug_Cst)2021 Drug cost: $18,338 (USD; Tot_Drug_Cst)2022 Drug cost: $40,846 (USD; Tot_Drug_Cst)2023 Drug cost: $62,059 (USD; Tot_Drug_Cst)2024 Drug cost: $16,839 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R25$500
20161578$1,362
20172358$1,448
20183495$18,365
201947104$7,514
202064167$15,248
202193319$18,338
2022147621$40,846
2023162651$62,059
2024117314$16,839

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more284284$134
92014Established patient complete exam of visual system421549$108
67028Injection of drug into eye251720$103
92012Established patient problem focused exam of visual system184233$82
92134Imaging of retina7171,433$36

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium271,539$3,617
Prednisolone AcetatePrednisolone Acetate683,143$2,738
Ketorolac TromethamineKetorolac Tromethamine401,903$1,503
CyclosporineCyclosporine14420$1,281
Brimonidine TartrateBrimonidine Tartrate462,639$1,262

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$950Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Reema Syed, MD?

Tedicare shows public-source Medicare data for Reema Syed, MD (NPI 1578806972), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Reema Syed, MD have ACO affiliation data?

Reema Syed, MD is shown with ACO affiliation data for Lore Health ACO (MSSP, ACO ID A5192).

What billing organization is linked to Reema Syed, MD?

Reema Syed, MD is linked to RETINAL DIAGNOSTIC CENTER A MEDICAL CORPORATION (billing NPI 1518030568) in the available physician profile data.

Does Reema Syed, MD have Open Payments data?

Reema Syed, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.